IPCA Laboratories

Market Cap

37,971.91 Cr

EPS

21.57

PE Ratio

47.03

Dividend Yield

0.27 %

Industry

Healthcare

52 Week High

1,755.90

52 Week low

1,052.00

PB Ratio

5.56

Debt to Equity

0.24

Sector

Pharmaceuticals

Investment Returns

In Long Term

In Short Term

1 Year

0.00%

2 Years

0.00%

3 Years

0.00%

4 Years

0.00%

5 Years

0.00%

Analyst Rating

- By Refinitiv from13 analysts

Analysts have suggested that investors can buy this stock

Buy76.92 %

76.92 %

Hold23.08 %

23.08 %

Sell0.0 %

0.0 %

Company News

View All News

Ipca Laboratories: Q3 Performance Exceeds Expectations, Analyst Raises Target Price6 days ago

Ipca Laboratories reported better-than-expected Q3 FY25 results, outperforming the industry in domestic formulation market. Motilal Oswal has raised the target price for Ipca Labs, citing growth driven by India operations and Unichem.

IPCA Labs Expands into Cosmeto Dermatology and Orthopedics6 days ago

IPCA Labs is diversifying its product portfolio by developing new products in the cosmeto dermatology sector. The company has also launched a new division called Flexicare, which will focus on products used in orthopedics. These strategic moves indicate IPCA Labs' efforts to expand its market presence and product offerings.

IPCA Labs Projects Margin Improvement and Strong EBITDA Outlook6 days ago

IPCA Labs anticipates a margin improvement of 100 to 150 basis points over the next three to four years. While the overall guidance for the year was around 21%, the company now expects standalone EBITDA to remain in the range of 23% to 24% for the entire financial year, as revealed in a concall update.

Peer Comparison Compare Peers on Screener

Competitors	LTP	Market Cap (₹ Cr.)	P/E Ratio	Revenue (₹ Cr.)	YoY Revenue Growth %	Net Profit (₹ Cr.)	YoY Profit Growth %	RSI
Sun Pharmaceutical	1,669.30	4,00,520.99	34.13	49,887.20	12.06	9,648	13.77	37.74
Divis Laboratories	5,978.30	1,58,705.08	76.14	8,184.00	0.89	1,600	64.53	51.57
Cipla	1,479.70	1,19,502.65	23.70	26,520.70	14.17	4,155	47.38	51.15
Torrent Pharmaceuticals	3,095.95	1,04,781.02	56.64	10,785.70	11.59	1,656	13.54	45.77
Dr Reddys Laboratories	1,170.95	97,705.34	18.09	28,905.40	12.36	5,578	1.69	30.83
Mankind Pharma	2,348.45	96,889.27	47.77	10,615.60	19.57	1,942	-16.38	39.42
Zydus Life Science	899.65	90,525.84	19.78	19,831.50	13.82	3,831	29.92	36.77
Lupin	1,977.50	90,213.07	31.46	20,141.50	19.94	1,936	38.82	38.83
Aurobindo Pharma	1,121.25	65,122.38	18.72	29,559.20	17.55	3,169	-10.04	42.81
Abbott	29,429.65	62,535.95	47.37	6,097.20	10.80	1,201	16.01	61.56

Growth Rate

Revenue Growth

22.92 %

Net Income Growth

7.58 %

Cash Flow Change

17.23 %

ROE

-17.67 %

ROCE

-3.19 %

EBITDA Margin (Avg.)

11.80 %

Quarterly Financial Results

Quarterly Financials	Jun 2018	Sept 2018	Dec 2018	Mar 2019	Jun 2019	Sept 2019	Dec 2019	Mar 2020	Jun 2020	Sept 2020	Dec 2020	Mar 2021	Jun 2021	Sept 2021	Dec 2021	Mar 2022	Jun 2022	Sept 2022	Dec 2022	Mar 2023	Jun 2023	Sept 2023	Dec 2023	Mar 2024	Jun 2024	Sept 2024	Dec 2024
Revenue	890	1,027	1,020	895	1,099	1,299	1,231	1,088	1,547	1,377	1,425	1,135	1,587	1,563	1,443	1,304	1,608	1,637	1,577	1,548	1,630	2,073	2,144	2,052	2,113	2,381	2,266
Expenses	757	838	772	716	881	1,019	942	908	947	1,003	1,045	886	1,152	1,184	1,123	1,070	1,317	1,341	1,330	1,331	1,278	1,713	1,722	1,848	1,700	1,913	1,782
EBITDA	133	188	247	179	218	279	289	180	599	374	380	249	435	378	320	234	291	296	247	217	353	360	422	204	413	468	483
Operating Profit %	14 %	17 %	23 %	19 %	18 %	21 %	22 %	15 %	38 %	26 %	26 %	21 %	26 %	23 %	22 %	17 %	17 %	16 %	14 %	12 %	19 %	16 %	16 %	9 %	19 %	19 %	21 %
Depreciation	47	45	46	45	46	50	51	64	51	52	54	53	56	57	59	61	62	64	67	70	69	90	100	98	99	100	99
Interest	5	2	5	6	5	4	4	4	3	2	2	2	2	1	1	3	7	9	11	19	31	44	33	29	24	23	17
Profit Before Tax	82	141	197	128	167	225	234	112	546	319	324	195	377	320	260	170	223	223	169	129	252	225	289	77	290	345	368
Tax	13	22	37	32	37	32	37	29	100	53	57	33	71	68	62	38	78	77	60	51	88	89	68	75	91	99	92
Net Profit	69	119	159	96	129	194	198	83	446	267	268	161	307	252	198	132	145	146	110	78	164	137	221	1	199	246	276
EPS in ₹	5.43	9.38	12.59	7.60	10.24	15.32	15.63	6.57	35.27	21.11	21.09	12.71	24.18	19.73	7.76	5.13	5.64	5.67	4.25	3.02	6.42	5.72	7.09	2.35	7.58	9.05	9.78

Show % Change

Above figures are in Rs. Crores

Balance Sheet

Balance Sheet	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total Assets	3,812	3,892	3,960	4,117	4,551	5,260	6,068	7,624	8,626	11,101
Fixed Assets	1,800	2,014	1,983	1,953	1,940	2,059	2,072	2,402	2,751	4,553
Current Assets	1,614	1,622	1,742	1,946	2,378	2,856	3,437	4,447	5,189	5,539
Capital Work in Progress	267	129	95	73	66	133	235	306	140	343
Investments	0	26	136	87	120	310	505	989	626	862
Other Assets	1,745	1,723	1,746	2,005	2,424	2,758	3,256	3,926	5,109	5,343
Total Liabilities	3,812	3,892	3,960	4,117	4,551	5,260	6,068	7,624	8,626	11,101
Current Liabilities	904	970	956	1,008	1,098	1,326	1,161	1,466	1,806	2,356
Non Current Liabilities	700	663	548	421	315	292	192	616	905	1,019
Total Equity	2,208	2,259	2,455	2,689	3,138	3,641	4,716	5,542	5,915	7,727
Reserve & Surplus	2,183	2,234	2,430	2,663	3,097	3,590	4,676	5,440	5,817	6,307
Share Capital	25	25	25	25	25	25	25	25	25	25

Show % Change

Above figures are in Rs. Crores

Cash Flow

Cash Flow	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Net Cash Flow	29	29	-26	75	153	-76	264	432	588	-823
Investing Activities	-689	-218	-149	-135	-165	-509	-521	-851	-725	-1,215
Operating Activities	468	709	282	341	501	570	1,090	856	806	945
Financing Activities	251	-462	-159	-130	-183	-137	-306	427	507	-553

Show % Change

Above figures are in Rs. Crores

Share Holding

% Holding	Mar 2021	Jun 2021	Sept 2021	Dec 2021	Mar 2022	Jun 2022	Sept 2022	Dec 2022	Mar 2023	Jun 2023	Sept 2023	Dec 2023	Mar 2024	Jun 2024	Sept 2024	Dec 2024
Promoter	46.29 %	46.29 %	46.29 %	46.29 %	46.29 %	46.29 %	46.29 %	46.29 %	46.29 %	46.29 %	46.29 %	46.29 %	46.30 %	46.30 %	46.30 %	44.72 %
FIIs	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.02 %	0.02 %	0.02 %	0.00 %	9.86 %	0.00 %	10.51 %	10.85 %	10.83 %	11.07 %
DIIs	24.49 %	24.86 %	25.00 %	29.73 %	32.41 %	33.31 %	33.29 %	34.03 %	33.55 %	35.19 %	35.05 %	33.79 %	34.37 %	33.78 %	34.23 %	35.68 %
Government	0.28 %	0.22 %	0.22 %	0.24 %	0.24 %	0.24 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %
Public / Retail	8.74 %	8.25 %	7.61 %	7.75 %	7.79 %	7.50 %	7.44 %	7.41 %	7.26 %	6.98 %	7.14 %	7.12 %	7.13 %	7.27 %	6.93 %	6.88 %
Others	20.20 %	20.39 %	20.89 %	15.99 %	13.27 %	12.66 %	12.97 %	12.26 %	12.89 %	11.54 %	1.67 %	12.80 %	1.69 %	1.79 %	1.71 %	1.65 %
No of Share Holders	1,00,626	1,05,428	95,239	1,06,779	1,15,335	1,10,818	1,11,043	1,08,177	1,10,296	99,889	95,930	82,809	81,165	84,753	82,975	90,189